Search

2 result(s) for 'author#"Mette Munk Jensen"' within BMC

1. [18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice

   Belinostat is a histone deacetylase inhibitor with anti-tumor effect in several pre-clinical tumor models and clinical trials. The aim of the study was to evaluate changes in cell proliferation and glucose upt...

   Authors: Mette Munk Jensen, Kamille Dumong Erichsen, Camilla Bardram Johnbeck, Fredrik Björkling, Jacob Madsen, Peter Buhl Jensen, Maxwell Sehested, Liselotte Højgaard and Andreas Kjær

   Citation: BMC Cancer 2013 13:168

   Content type: Research article

   Published on: 1 April 2013

   • View Full Text
   • View PDF

2. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by ¹⁸F-FDG-microPET or external caliper

   In animal studies tumor size is used to assess responses to anticancer therapy. Current standard for volumetric measurement of xenografted tumors is by external caliper, a method often affected by error. The a...

   Authors: Mette Munk Jensen, Jesper Tranekjær Jørgensen, Tina Binderup and Andreas Kjær

   Citation: BMC Medical Imaging 2008 8:16

   Content type: Research article

   Published on: 16 October 2008

   • View Full Text
   • View PDF